Potential impact of celiac disease genetic risk factors on T cell receptor signaling in gluten-specific CD4+T cells by Bakker, Olivier B. et al.






The following full text is a publisher's version.
 
 









Scientific Reports |         (2021) 11:9252  | https://doi.org/10.1038/s41598-021-86612-5
www.nature.com/scientificreports
Potential impact of celiac disease 
genetic risk factors on T cell 
receptor signaling in gluten‑specific 
CD4+ T cells
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Niek de Klein 1,9, Yang Li 1,9, Rutger Modderman 1, Yvonne Kooy‑Winkelaar2, 
Marie K. Johannesen3,4, Filomena Matarese5, Joost H. A. Martens 5, Vinod Kumar 1,6,7, 
Jeroen van Bergen2, Shuo‑Wang Qiao 3,4, Knut E. A. Lundin 3,8, Ludvig M. Sollid 3,4, 
Frits Koning 2, Cisca Wijmenga 1,3, Sebo Withoff 1 & Iris H. Jonkers 1*
Celiac disease is an auto‑immune disease in which an immune response to dietary gluten leads to 
inflammation and subsequent atrophy of small intestinal villi, causing severe bowel discomfort and 
malabsorption of nutrients. The major instigating factor for the immune response in celiac disease is 
the activation of gluten‑specific CD4+ T cells expressing T cell receptors that recognize gluten peptides 
presented in the context of HLA‑DQ2 and DQ8. Here we provide an in‑depth characterization of 28 
gluten‑specific T cell clones. We assess their transcriptional and epigenetic response to T cell receptor 
stimulation and link this to genetic factors associated with celiac disease. Gluten‑specific T cells have 
a distinct transcriptional profile that mostly resembles that of Th1 cells but also express cytokines 
characteristic of other types of T‑helper cells. This transcriptional response appears not to be regulated 
by changes in chromatin state, but rather by early upregulation of transcription factors and non‑
coding RNAs that likely orchestrate the subsequent activation of genes that play a role in immune 
pathways. Finally, integration of chromatin and transcription factor binding profiles suggest that 
genes activated by T cell receptor stimulation of gluten‑specific T cells may be impacted by genetic 
variation at several genetic loci associated with celiac disease.
In celiac disease (CeD), cereal-derived gluten peptides penetrate the small intestinal barrier, are subsequently 
modified by tissue trans-glutaminase 2 (TG2), then presented by HLA-DQ2- or HLA-DQ8-positive antigen-
presenting cells (APCs) to gluten-specific CD4+ T-helper cells (gsTcells)1. This leads to robust activation of 
gsTcells that subsequently stimulate B cells to start producing auto antibodies to TG2 and deamidated gluten 
 peptides1,2 and activate CD8+ intraepithelial lymphocytes (IELs) to attack intestinal epithelial cells, leading to 
the villous atrophy that is characteristic of CeD. GsTcells are only found persistently in CeD  patients3,4 and can 
induce villous atrophy in patients upon gluten ingestion even after these individuals have been on a gluten-free 
diet for  years5. Activation of gsTcells is thus central to CeD onset and pathology.
GsTcells have been shown to secrete many signaling molecules upon stimulation, including interleukin (IL)-
2, IL-4, IL-6, IL-8, IL-10, IL-21, CD40LG, IFNγ and TNF, and are often classified to be of type 1 helper  class6–12. 
GsTcells uniquely express IL-21 and CXCL13, as well as several other markers characteristic of follicular and 
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regulatory T  cells13. IL-21 and CXCL13, together with CD40LG and IL-4, play an important role in the inter-
action, differentiation and activation of T cells and plasma B  cells13–16. Cytokines secreted by gsTcells are also 
important for activation and proliferation of IELs, in combination with IL-15, a cytokine important in CeD 
etiology that is produced by  IELs17–20. GsTcells are thus central in the response to gluten peptides that leads to 
inflammation, anti-TG2 antibody production and villous atrophy in CeD.
To date, 43 genetic risk factors have been associated with  CeD21–23, the most important being the HLA haplo-
types HLA-DQ2 and -DQ8. While the role of HLA-DQ2 and -DQ8 in CeD is well  defined24–26, the contribution 
of the non-HLA CeD risk-loci is mostly unclear. More than 95% of the single nucleotide polymorphisms (SNPs) 
associated with CeD are located in the non-coding genome and presumably deregulate genes important for CeD 
 etiology27. Enrichment analysis of the CeD SNPs in regulatory regions suggests that CD4+ T cells are the major 
cell type affected by genetic risk  factors28–30. Moreover, pathway and cis-eQTL analyses of genes in CeD loci 
suggest that they affect T cell receptor (TCR) signaling via alteration of expression of genes such as UBASH3A, 
CD28 and CSK30–32. Overall, these observations confirm the importance of CD4+ T cell activation in CeD but 
do not delineate how CeD-associated SNPs affect gsTcells upon activation.
This knowledge gap is partially due to an incomplete understanding of the regulation of the response to 
stimulation in gsTcells. Recently, it was shown that the genetic risk loci associated with CeD are enriched with 
binding sites of specific transcription factors (TFs), including STAT4, STAT5A, STAT5B, T-BET, AP-1 subunit 
FOS and TFs from the NFκB signaling  pathway29. Indeed, many of these TFs have been implicated in regulation 
of CD4+ T cell activation or in  CeD12,33–36. However, the role of these TFs, as well as the dynamic transcriptional 
and epigenetic response in the activation of gsTcells, has not been described. Nor has the role of CeD-associated 
genetic variants in these dynamic transcriptional processes been explored in gsTcells.
Here, we set out to profile the transcriptomic and epigenetic response of gsTcells derived from CeD patients 
upon TCR-stimulation with anti-CD3 and anti-CD28 (aCD3/aCD28). This allowed us to identify the regula-
tory steps essential for the rapid and robust activation of cytokines important for CeD etiology and to prioritize 
which CeD-associated risk loci are related to the activation of gsTcells. Overall, we elucidate the dynamic events 
in gsTcells that can be induced by gluten peptides in CeD patients.
Results
Dynamic transcriptome changes in stimulated gsTcells. To study the TCR-induced response of 
gsTcells, we opted for aCD3/aCD28 stimulation as a proxy for the interaction of gsTcell-TCR with gluten pep-
tides presented by antigen-presenting cells in the context of HLA-DQ2 or -DQ8. Twenty-three CD4+ gsTcell 
clones isolated from biopsies from patients with active CeD were cultured and stimulated in vitro and used to 
perform transcriptomic (RNA-Seq; n = 23) and targeted proteomics analysis (n = 3) (discovery cohort, Suppl. 
Table 1). An additional five gsTcell clones were used for replication of the transcriptomic data and detection of 
open chromatin through DNase-Hyper-Sensitivity sequencing (DHS-sequencing) (Fig. 1A, Suppl. Table 1). The 
transcriptomic response of gsTcells to stimulation showed strong and consistent effects after 180 min relative 
to the earlier timepoints. Although there was considerable inter-clonal variation, the replication and discovery 
cohorts behaved very similarly (Fig. 1B). We used the discovery cohort to determine the dynamic transcriptional 
response of genes during the course of the stimulation, which showed clear distinctions between each time 
point (Suppl. Fig. 1). We performed differential expression (DE) analysis between consecutive timepoints to 
reveal the changes in gene expression over time. Between 0‒10 min, 10‒30 min and 30‒180 min, 115, 182 and 
3339 DE genes were identified, respectively (Fig. 1C, Suppl. Table 2). Finally, non-coding genes were found to 
be differentially expressed at all timepoints, but at 180 min the downregulated set was roughly twice as large as 
the upregulated set, which was not the case for the coding genes (Fig. 1C). GsTcell clones thus rapidly displayed 
strong and dynamic transcriptional changes after stimulation.
DE genes cluster into response patterns with distinct functions. To understand and categorize 
the activation of gsTcells, we clustered the DE genes using k-means clustering to identify temporal response 
patterns. This identified six distinct clusters that each represent a specific response (Fig. 2A, Suppl. Fig. 2, Suppl. 
Table 2). Genes in Clusters 1 (n = 366) and 2 (n = 162) were upregulated early (at 10 min). In contrast, cluster 3 
genes (n = 1002) were upregulated after 30 and 180 min. Cluster 4 (n = 609) genes displayed an early decrease but 
recovered after 180 min. Cluster 5 (n = 588) genes responded similarly to cluster 1 genes, but their gene expres-
sion levels after 180 min were decreased compared to unstimulated expression levels. Finally, cluster 6 genes 
(n = 782) show a consistent late decrease in expression.
Gene set enrichment analysis using the Reactome database pinpointed enriched gene sets (false discovery 
rate (FDR) < 0.05) for clusters 2, 3, 4 and 6 (Fig. 2B) but found no enrichment in clusters 1 and 5. Cluster 2 is 
enriched for Nuclear Receptor transcription pathway genes (NR4A1, NR4A2 and NR4A3) and IL10 signaling 
genes (TNF and ICAM1). Cluster 3 is predominantly associated with immune function, showing an enrichment 
of cytokine signaling pathway genes. Moreover, genes associated with transcriptional and translational processes 
are also enriched in cluster 3, consistent with an immune response that requires the production and secretion 
of cytokines and other signaling proteins. Cluster 4 is enriched in translational and mitochondrial response 
genes that are associated with a shift towards protein production. Finally, the downregulated genes in cluster 
6 are enriched in genes involved p53-mediated regulation of caspases. Downregulation of cluster 6 genes may 
thus decrease apoptosis and cell death and favor proliferation, paving the way for a robust immune response by 
gsTcells that is mediated by the genes in cluster 3.
To ascertain how these pathways might be regulated, we investigated the relative enrichment of non-coding 
RNAs (ncRNAs) per cluster. The early-responding clusters 1, 2 and 5 are enriched for ncRNAs, implying that 
these RNAs play a role in regulating expression of genes at 180 min, when protein-coding genes are enriched 
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(clusters 3, 4 and 6) (Fig. 2C). Several genes encoding TFs that mediate early immune and stress responses are 
also found in clusters 1 and 2. These TFs include all EGR TFs, NR4A1, NR4A2, NR4A3, ATF3, FOS and FOSB, of 
which the latter two are subunits of AP-1 (Suppl. Fig. 3A). Additionally, cluster 3 encompasses REL (encoding 
NFκB subunit c-REL), NFκB1 (encoding NFκB subunit p50) and the NFκB inhibitory genes NFκBIA, NFκBID 
and NFKIZ, which suggests an early activation of the NFκB pathway and a subsequent feedback loop after 
180 min (Suppl. Fig. 3B)37,38. Thus, the action of several TFs that are either activated or transcribed soon after 
stimulation, possibly in conjunction with ncRNAs, seems to mediate the strong response of genes after 180 min.
To confirm that transcriptional changes lead to secretion of cytokines, we measured a panel of 92 proteins in 
the gsTcell culture medium after 4 h of stimulation. Thirty of these proteins are encoded by genes differentially 
expressed during the stimulation of gsTcells (Suppl. Fig. 4A, Suppl. Table 3). We found that levels of IL-21, 
CD40LG, IL-2, IL-4 and TNF were significantly increased (nominal p value < 0.05) (Fig. 2D) in concert with 
increased expression of their corresponding genes (Suppl. Fig. 4B). These cytokines all have pro-inflammatory 
roles and contribute to activation and proliferation of other cell types, including B cells (IL-21, IL-4 and CD40LG) 
and other T cells like IELs (IL-2 and TNF)39,40.
Figure 1.  Stimulation of gluten-specific CD4+ T cells with aCD3/aCD28. (A) Experimental scheme of the 
discovery and replication cohort. The ‘+’ symbol indicates that a measurement is available at that timepoint. 28 
gsTcell clones were isolated from CeD biopsies, 23 clones were used in discovery analysis and 5 were used for 
replication and DHS-sequencing. A final 3 clones from the discovery set were used for proteomic analysis. (B) 
PCA of the complete expression data of the discovery (circles) and replication (diamonds) cohorts. Each time 
point is indicated in a different color. (C) Differentially expressed genes identified by differential expression 
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In summary, the distinct and dynamic transcriptional changes we observe represent a robust translational 
immune response to TCR activation that leads to the secretion of several cytokines within 4 h.
Transcriptional changes identified in gsTcells upon activation are similar to those in other T 
cells. To examine the specificity of the gsTcell response, we compared the DE genes of gsTcells (between 0 
and 180 min) to those of naïve CD4+ T cells stimulated with aCD3/aCD28 [DICE consortium (n = 90)]41. A large 
proportion (57%) of the DE effects we observed in gsTcells were also found in the DICE consortium data (96% 
directional concordance; Fig. 3A, Suppl. Tables 4, 5). Directionally concordant genes (Q1 and Q3 in Fig. 3B) 
showed an enrichment for genes involved in interleukin signaling and rRNA processing (Suppl. Fig. 5A), as 
we had observed in cluster 3 (Fig. 2B), suggesting this to be a general response of CD4+ T cells to stimulation. 
Genes uniquely activated in gsTcells include chemokines such as CCL1, CXCL1 and CCL4L1, which encode for 
peptides that bind the receptors CCR8, CXCR2 and CCR5 and that can mediate recruitment of immune cells, 
including Type 2 innate lymphocyte cells, neutrophils and activated CD8+ T cells, respectively (Fig. 3C, Suppl. 
Fig. 6A)42. In addition, the cytokine-encoding genes IL5, IL9, IL19, IL17F and IL26, as well as RORC (encoding 
for TF RORγt), are uniquely differentially expressed in gsTcells, albeit at low levels, and each points to a different 
subset classification of T helper cells for  gsTcells43.
To determine which T helper subset the gsTcells most resemble, we compared the expression patterns of the 
main cytokines associated with Th1 (IFNG, TNF), Th2 (IL4, IL5, IL13), Th17 (IL17A), Treg (IL10, TGFB1), T 
follicular helper (IL21) and Th9 (IL9) cells (Suppl. Fig. 6B)6–13,43,44. We observed that cytokines characteristic for 
several subsets are strongly upregulated upon stimulation, with Th1 cytokines most strongly expressed. GsTcells 
are therefore most similar to Th1 cells but also share characteristics with multiple Th subsets.
Overall, the strong concordance between the TCR-induced response profile of naïve CD4+ T cells and gsT-
cells (Fig. 3A, B) suggests that the TCR response is largely shared in CD4+ T cells. However, we also observed 
1371 unique DE genes that were not observed in the naïve CD4+ T cells or biopsy-derived gsTcells. This set of 
genes was mainly upregulated (1047/1371) and was enriched for G protein‒coupled receptor ligand binding, 
IL-6–type cytokine receptor ligand interaction and peptide ligand‒binding receptors (Fig. 3E). Nonetheless, 
when compared to naïve CD4+ T cells, in vitro-cultured gsTcells show a distinct response profile on top of the 
shared TCR response profile that includes a diverse set of cytokines and chemokines that are comparable to that 
of Th1, Tfh and Th2 cells, which is consistent with previous  evidence6–13,43,44.
The expression profile of in vitro‒cultured gsTcells is similar but not identical to the expression 
profile of gsTcells isolated directly from biopsies. Next, we compared the transcriptomic response of 
our cultured gsTcells with gsTcells taken directly from CeD biopsies 6 days after an in vivo gluten  challenge13. 
These biopsy-derived gsTcells were obtained from Christophersen et al.13 and contained tetramer+ CD4+ T cells 
and tetramer− CD4+ T cells from CeD patients (n = 5) and gut CD4+ T cells from healthy controls (n = 4). We 
found that 123 out of 3395 DE genes in gsTcells are shared with the 865 DE genes from biopsy-derived gsTcells (p 
value = 0.0056; two-sided Fisher’s exact test) (Fig. 3D, Suppl. Tables 4, 6). These overlapping genes were enriched 
for the ’TNFR2 non-canonical NFκB pathway’ in Reactome and included immune genes such as CD200, 
MAP4K3 & PDCD1, IL21 (a key regulator in CeD) and IL22 (a regulator of intestinal epithelial  homeostasis45) 
(Suppl. Fig. 5B, Suppl. Table 7). The differences between the in vitro-cultured gsTcells and biopsy-derived gsT-
cells could partly be attributable to differences in sample size. Moreover, the in vitro‒cultured gsTcells were 
stimulated for 3 h, and the DE genes therefore reflect early transcriptional changes upon stimulation, which 
may not reflect the activation state of in vivo biopsy-derived gsTcells. Finally, continuous in vitro culturing of 
the gsTcell clones in the presence of IL-2 and IL-15 is likely to introduce changes in the expression profile of the 
gsTcell clones compared to the biopsy-derived gsTcells. Thus, gsTcells show disease-relevant characteristics but 
are not identical to ‘fresh’ biopsy-derived gsTcells.
Chromatin of gsTcells remains largely stable. Next, we assessed if changes in chromatin state agreed 
with changes in gene expression upon stimulation of gsTcells. We observed that the chromatin state measured by 
DHS-seq remained mostly stable at all four timepoints when assessed genome-wide, and most of the variation in 
open chromatin was explained by which gsTcell clone the data was derived from, and not by stimulation effects 
(Fig. 4A, Suppl. Table 8). Nonetheless, when investigating the open chromatin sites in a 5 kb window around 
the 3509 DE genes, we observed some variation between t180 and the other timepoints (Fig. 4B). However, dif-
ferential peak-calling analysis did not find any sites with a log2 fold change > 1. These results are probably due to 
the large variation between the clones (Fig. 4A, B) and the modest sample size. We also investigated the overlap 
Figure 2.  Differentially expressed genes cluster into response patterns showing distinct functions. (A) Cluster 
analysis identified 6 robust clusters encompassing the response profiles of all 3509 differentially expressed (DE) 
genes. Numbers of genes per cluster are shown. Y-axis shows the mean expression of the genes at each respective 
time point, centered to mean zero and scaled to standard deviation one. (B) Reactome gene set enrichment 
analysis shows enriched pathways for 4 out of the 6 clusters. (C) Enrichment analysis by Fisher’s exact test 
of non-coding RNAs per cluster. Significance is shown in shades of red. Log2 odds ratios are plotted on the 
x-axis and indicate enrichment or depletion. Error bars indicate 0.95 confidence intervals. (D) Scaled relative 
protein levels (Olink) in the unstimulated condition and after 4 h of stimulation for the three independent 
experiments (black dots). Box colors above the dotplots indicate the cluster in which the DE genes are found. 
Mean, minimum and maximum relative protein levels are indicated in red. Nominal significance is indicated by 
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Figure 3.  The transcriptional response of gsTcells shows differences and similarities with other T cells. 
(A) Upset plot comparing significant DE genes between stimulated naïve CD4+ T cells (DICE) (t0 vs t240, 
FDR < 0.05 and absolute log2FC > 1)41, gsTcells (t0 vs t180, FDR < 0.05 and absolute log2FC > 1) and biopsy-
derived gsTcells (gsTcells vs CD4+ T cells in cases/controls, FDR < 0.05 and absolute log2FC > 2)13. At the top, 
the size of the intersecting sets with gsTcells are indicated in light blue, non-overlapping genes with gsTcells 
are shown in light green and genes unique to gsTcells are shown in dark blue. The right barplot shows the total 
number of DE genes per dataset. (B) Scatterplot of log2FC of DE genes between DICE (y-axis) and gsTcells 
(x-axis). Numbers in light blue indicate the number of genes in each quadrant that are significant in both 
analyses. (C) Gene set enrichment analysis done using Reactome of DE genes unique for gsTcells as compared 
to DICE naïve CD4+ T cells (adjusted p value < 0.05, absolute log2FC > 2). At the bottom is the direction of 
expression of the DE genes in gsTcells. Numbers in brackets indicate the number of DE genes present in all 
enriched pathways. Dot size indicates the ratio of the number of genes present in the gene set and the total gene 
set used in each pathway. (D) Comparison as in (B) for DE effects in CeD biopsy-derived gsTcells (y-axis). (E) 
Gene set enrichment analysis as in (C) for genes unique to gsTcells compared to CeD biopsy-derived gsTcells 
and DICE naïve CD4+ T cells (adjusted p value < 0.05, absolute log2FC > 2).
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between peaks in each clone and compared that to the overlap between ATAC-seq peaks in naïve CD4+ T cells 
in a similar stimulation  experiment46. Overall, the naïve CD4+ T cells showed more stimulation-specific effects, 
with 25% of peaks being shared at all four timepoints, as opposed to gsTcells, where 45% of the peaks are shared 
(Fig. 4C). Moreover, TF binding site enrichment analysis on peaks uniquely present in unstimulated gsTcells, but 
not seen in naïve CD4+ T cells under unstimulated conditions, showed that AP-1 binding sites are enriched in 
gsTcells even prior to stimulation (HOMER, p value = 1e−16). Altogether, this suggests that the early upregula-
tion of gene expression upon activation in gsTcells is mostly independent of chromatin state and instead driven 
by the interplay of TFs and ncRNAs.
Figure 4.  Open chromatin changes are minimal in gsTcells upon stimulation. (A) PC analysis of all peaks 
in each individual gsTcell clone in the discovery cohort. Timepoints indicated by shapes, clones by colors. 
(B) As in (A), but only using peaks within a 5 KB window around the transcription start sites of the 3509 DE 
genes in the PCA. (C) Comparison of the relative changes in the individual gsTcells and naïve CD4+ T cells of 
two individuals between all timepoints. Overlaps between all timepoints were calculated using the multiinter 
Bedtools function, and the relative number of overlaps is plotted for each. Peaks that are present at all timepoints 
are represented in the ‘4’ category. Peaks unique to one time point are represented in the ‘1’ category. Clones are 
indicated with the same colors as in (A) and (B). Nominal significance indicated with asterisks (*p value < 0.05, 
**p value < 0.01 and ***p value < 0.001).
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DE genes show enrichment for CeD loci and CeD‑associated genes. To ascertain if the DE genes 
we found are affected by the genetic background associated with CeD, we integrated our transcriptional data 
with 118 cis-genes for CeD identified by a previous gene prioritization  effort30 (Fig. 5A). We observed that 26 of 
the prioritized genes are DE in the gsTcells. Of these 26 genes, 18 belong to cluster 3, in which immune response 
pathways are overrepresented, consistent with the mostly T cell–based GWAS signal of  CeD23. Of particular 
interest are IL21 and other cytokine-encoding genes (IL2, TNFSF11 and FASLG), several cytokine receptor genes 
(IL21R, IL1RL1, TNFRSF9 and IL2RA) and genes for TFs that can play a role in immune response (REL, BACH2 
and IRF4). Interestingly, UBE2E3, CSK and SLC22A4 are DE in gsTcells but not in naïve CD4+ T cells (Fig. 3B), 
which implies that these genes may have a relatively specialized function in gsTcells.
We subsequently checked if the DE genes were overrepresented in CeD  loci23 using genomic region enrich-
ment analysis (GREA)19 (Fig. 5 B,C; Suppl. Fig. 8). GREA operates by comparing the overlap of DE genes in a 
window of ± 125 kb around a CeD locus to the overlap found randomly in a permutation-based null distribution. 
We found no significant enrichment for genes located in CeD loci when assessing all 3509 DE genes (Fig. 5B). 
However, when we assessed the enrichment per cluster (Suppl. Fig. 8), cluster 3 showed a nominally significant 
enrichment for genes located in CeD loci (p value = 0.042; Fig. 5C), with around 18% of cluster 3 genes being 
located near a CeD locus. Thus, the genes in cluster 3 may be affected by the genetic predisposition for CeD.
Next, we assessed whether any of the TFs that were DE in gsTcells were enriched to bind in CeD loci using 
REgulatory trait Locus Intersection (RELI) in conjunction with the provided database of ChIP-seq data for 
389 TF‒cell type  pairs29. In total, 98 TF–cell type pairs showed significant enrichment for binding in CeD loci 
(FDR < 0.05) (Suppl. Table 9). Of these TFs, FOS, STAT5A and T-BET (encoded by the gene TBX21) were of par-
ticular interest as their genes showed a DE effect in gsTcells and the ChIP-seq data used in RELI was derived from 
CD4+ T cells. FOS falls in cluster 1 and showed an early but transient response to stimulation (Suppl. Fig. 9A), 
whereas STAT5A and TBX21 showed a later response corresponding to the cluster 3 profile (Suppl. Fig. 9B and 
Figure 5.  DE genes show enrichment for CeD loci. (A) Genes prioritized from CeD  loci30 were overlapped 
with DE genes and plotted per CeD locus. Log2 fold change between timepoints is indicated, and clusters are 
depicted with colored boxes (right). (B) Enrichment of DE genes over the null distribution (histogram) in CeD 
loci (± 125 kb window around start and end of gene) using  GREA19 for all DE genes (n = 3509). X-axis indicates 
the number of genes that overlap with CeD loci as a percentage. The histogram shows the null distribution based 
on 10,000 permuted gene-sets. The black line indicates the value of the true gene-set. Nominal p values are 
indicated. (C) As in (B), but only for genes in cluster 3 (n = 1002).
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C, respectively). FOS is a well-known early response immune and stress response TF that can heterodimerize 
with the JUN or ATF TF families. Indeed, ATF3 is also DE and has a very similar transcriptional profile to FOS 
(Suppl. Fig. 3A). STAT5A is required for IL2 signaling in CD4+ T  cells47, and T-BET is the major TF for Th1 
differentiation, expression of IFNγ and other Th1-specific  cytokines48. Thus, these TFs all have prominent roles 
in CD4+ T cell differentiation and activation.
To explore if any of the SNPs in the 43 CeD loci from the latest CeD meta-analysis23 could directly affect gene 
regulation in gsTcells, we overlapped the TF binding sites of FOS, STAT5A and T-BET with the open chromatin 
regions, CeD GWAS summary  statistics32, DE information, ATAC-seq of naïve CD4+ T  cells46 and capture Hi-C 
data of activated CD4+ T cells (Fig. 6). We found one locus of interest near the IL18RAP/IL1RL1 genes. In this 
locus, one SNP (rs1420106, GWAS p value 8.7e−14) located in the promoter of IL18RAP overlapped with all 
three of the enriched TF binding sites, a DHS peak from gsTcells and an ATAC-seq peak from naïve CD4+ T 
cells (Fig. 6A). We assessed if this locus could act as an enhancer using publicly available capture Hi-C data from 
activated CD4+ T  cells49 and found interactions with the promoters of IL1RL1 and IL18R1 (Fig. 6A). Moreover, 
rs1420106 strongly affected the expression of IL18RAP, IL1RL1 and IL18R1 (eQTL p values 3.27e−310, 1.95e−144 
and 1.63e−185, respectively) in whole blood (eQTLgen  database50). Finally, both IL1RL1 and IL18RAP were sig-
nificantly upregulated in gsTcells at t180 compared to t0 (Fig. 6B). Together, this suggests that rs1420106 might 
Figure 6.  Rs1420106 in the IL1RL1/IL18R1/IL18RAP locus overlaps with open chromatin and TF binding sites 
in gsTcells. (A) Overview of the IL1RL1/IL18R1/IL18RAP locus. From top to bottom: summary statistics of the 
CeD GWAS meta-analysis22 (green); TF binding sites based on Chip-seq of FOS (red), STAT5A (orange) and 
T-BET/TBX2129 (brown); DHS profile of unstimulated gsTcells with peak calls depicted below (light blue); peaks 
from naïve CD4+ T cell ATAC-seq46 (dark blue); capture Hi-C data of activated CD4+ T cells depicting the 3D 
interactions between the highlighted region and other locations in the  locus82 (grey) and the gene annotations. 
The prioritized SNP rs1420106 is indicated in dark blue. (B) Gene expression pattern of genes in the locus. 
Y-axis represents the VST-normalized expression data. Black line and number indicate the adjusted p value 
(DeSeq2) of the DE effect between the t0 and t180 timepoints. Blood eQTL p values of SNP rs1420106 for the 
indicated genes are: IL18RAP, 3.27e−310; IL1RL1, 1.95e−144 and IL18R1, 1.63e−185 (eQTLgen.org50).
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have a role in the activation response of gsTcells by modifying the expression of IL18RAP, IL1RL1 and IL18R1. 
Similarly, we identified three more CeD loci (containing genes BACH2, IL21-IL2 and TAGAP) that showed 
overlap of SNPs associated with CeD with DHS sites found in gsTcells that also bind the TFs FOS, STAT5A and/
or T-BET (Suppl. Figs. 10–12).
Thus, CeD-associated genetics may play a complex role in gsTcells during activation of these important cells 
in CeD pathology.
Discussion
In this study, we characterized gsTcells, one of the key players in CeD pathogenesis, by profiling transcriptomic 
and epigenetic changes during the early response to aCD3/aCD28 activation. We pinpointed pathways and TFs 
that may regulate these cells and confirmed that gsTcells are not restricted to any specific class of Th cells, but 
rather express cytokines, chemokines and TFs that are characteristic of Th1 but also of Tfh and Th2 subsets. We 
also identified CCL1, CXCL1 and CCL4L1 as unique DE genes that had not previously been shown to be expressed 
by CD4+ T cells in the context of CeD. Finally, we showed that the early response of gsTcells to stimulation is 
regulated by rapid upregulation of many TFs and ncRNAs in combination with the activation of JNK/AP-1 and 
NFκB TFs, whereas changes in chromatin were minor. Overall, our results provide an in-depth analysis of the 
molecular pathways that are activated in gsTcells upon TCR activation.
Our study illustrates that gsTcells express and secrete cytokines that can be associated to various subsets of 
Th cells, most prominently with the Th1 (IFNG and TNF), Th2 (IL4, IL5, IL13) and Tfh (IL21) subsets, which is 
in agreement with previous  studies6–13,43,44. Based on their unique cytokine profile, gsTcells may exert multiple 
functions in CeD pathogenesis. Firstly, IFNγ is important for eliciting a strong response to foreign antigens such 
as the gluten peptides in  CeD51. Moreover, IFNγ can also directly affect the integrity of the intestinal  barrier52. 
Secondly, Th2-associated cytokines and IL-21 produced by Tfh cells are important for plasma cell differentiation, 
B cell activation and autoantibody  production43. Finally, IL-21, IL-2 and TNF have been shown to activate CD8+ 
T cells and IELs in the gut, which thereby become “licensed to kill” epithelial cells, leading to the villus atrophy 
in  CeD12,19,20,53. Thus, cytokines derived from gsTcells may play a role in several distinct disease mechanisms.
Our comprehensive analysis of the regulatory mechanisms that drive gene expression in activation of gsTcells 
agrees in part with the results of a study where the authors analyzed biopsy-derived gsTcells (Christophersen 
et al.13) but also uncovered differences. These differences might be due to differences in sample size and experi-
mental design between the two studies but may also reflect the fact that the gsTcells used in our study have been 
expanded in vitro in the presence of IL-2 and IL-15. Nonetheless, the unique expression of genes that are not DE 
in activated naïve CD4+ T cells and the enrichment of genes that overlap with genes specific to biopsy-derived 
gsTcells suggest that in vitro‒cultured gsTcells are a unique and appropriate model to delineate the dynamic 
transcription and regulation of gsTcells.
Similarly, comparison with other datasets such as the DICE data (Fig. 3A, B) and CeD-patient derived CD4+ 
T cells from PBMCs described by Quinn et al. (data not shown), validate our findings that the gsTcells have 
a similar but distinct expression profile and that important cytokines and other genes are associated to CeD 
etiology, such as IFNG, IL21, IL17A and IL454, are differentially expressed. Still, the unique expression profile of 
gsTcells relative to naïve or blood-derived CD4+ T cells may be lost if the comparison with other antigen-specific 
T cells or memory CD4+ T cells activated with similar stimuli and timepoints.
Based on the expression pattern of the DE genes, we identified six major gene clusters with distinct dynamic 
responses and functions. Early responding genes were represented by clusters 1, 2 and 5 and contained multiple 
TFs, some cytokines and a disproportionate number of ncRNAs, implying that these genes regulate the response 
at later time points. An earlier study also observed a ncRNA response during the activation of lymphocytes, which 
supports the idea that ncRNAs are key in the development and activation of CD4+ T  cell55. Some ncRNAs that are 
DE in gsTcells have also been implicated in immune activation, inflammation and proliferation in other studies, 
including LINC00174, AF131217.1, TINCR and LINC00342, which were all found in cluster  156–60. Thus, ncRNAs 
seem to play a pivotal role in the immune response by changing the expression of specific genes in gsTcells.
The gsTcells we studied showed a stable open chromatin profile genome-wide, with only minor changes upon 
stimulation near the transcription start sites of DE genes. However, we cannot exclude the possibility that the 
stability we observe is a consequence of culturing gsTcells in the presence of cytokines to induce  expansion61. In 
contrast to the stable open chromatin profiles in gsTcells, the transient expression of specific TFs and ncRNAs, 
in concert with the activation of common signaling pathways like JNK/AP-1 and NFκB, may be the source of 
the unique expression profile observed in the gsTcells.
Several DE genes are located in CeD-associated loci, and we found a subtle enrichment for genes of immune 
cluster 3 in CeD loci. However, the largest CeD association study to date was performed using the Immunochip 
platform, which is enriched for known immune regions, and thus we may have missed enrichment in other 
functional clusters. Nonetheless, 18% of the genes in cluster 3 are located in CeD loci, highlighting that TCR-
mediated T cell activation, particularly in gsTcells, may be affected by CeD-associated SNPs.
To ascertain the role of CeD-associated SNPs in regulating gene expression in gsTcells, we integrated multiple 
publicly available functional data layers with the gene expression and DHS regions of the gsTcells and CeD-
associated SNPs. While this integration provides suggestive evidence that the prioritized SNPs have regulatory 
potential in gsTcells, we cannot directly confirm that the genetic effect has a regulatory role. This would require 
an eQTL analysis with primary gsTcells derived from biopsies or functional validation by targeting these candi-
date regulatory elements, both of which are beyond the scope of this study. Despite these challenges, we provide 
evidence for potential genetic interference of CeD-associated SNPs in gsTcells in several loci and pinpoint several 
SNPs and regulatory regions within the genome that are the most likely candidates to cause this interference.
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In summary, we present an in-depth characterization of early transcriptional dynamics of gsTcells in response 
to TCR activation. We highlight that this transcriptional response is most likely regulated by TFs and ncRNAs 
rather than large changes in chromatin state. Finally, we prioritize several CeD-associated genetic loci that may 
impact the TCR-activation in gsTcells directly.
Methods
Obtaining T cell clones from biopsies of CeD patients. Gluten-specific CD4+ T cells were isolated 
from CeD patient small intestinal biopsies, as described  previously25,62–65. Patients were diagnosed with CeD 
with small bowel biopsy confirmation and included at Leiden University Medical Center (LUMC), the Nether-
lands (n = 18), and the Riks Hospital in Oslo (RHO), Norway (n = 4), from which 23 and 5 gluten-specific T cell 
lines were isolated, respectively (Suppl. Table 1). Briefly, written informed consent was given by all patients and 
the small intestine biopsies from CeD patients were cultured with a mixture of gluten and TG2-treated gluten 
(deamidation) for 5 days. To expand the T cells, IL-2 (20 Cetus units/ml; Novartis, Arnhem, the Netherlands) 
and IL-15 (10 ng/ml; R&D systems, Abingdon, UK) were added. Subsequently, irradiated allogeneic peripheral 
blood mononuclear cells in the presence of phytohemagglutinin (1 μg/ml; Remel Inc. Lenexa, USA), IL-2 (20 
Cetus units/ml) and IL-15 (10 ng/ml) were mixed with T cells for re-stimulation25. The resulting T cell clones 
were tested for reactivity against gluten digested by pepsin and trypsin and TG2-treated in proliferation assay. 
The pepsin/trypsin digest of gluten was prepared as described by Van de Wal et  al.63. For deamidation, the 
pepsin/trypsin-digested gluten (500 mg/ml) was incubated with 100 mg/ml of guinea pig tTG (T-5398; Sigma, 
St. Louis, MO) at 37 °C for 2 h in PBS with 1 mM  CaCl2 and subsequently used in T cell proliferation assays. 
Proliferation assays were conducted as described by Van de Wal et al.63, for samples from LUMC, and Molberg 
et al.65, for samples from RHO. Gluten-specific lines were cloned by limiting dilution and expanded again by 
re-stimulation at 1- to 3-week  intervals25. Clones were stored in liquid nitrogen. All methods were performed in 
accordance with relevant guidelines and regulations.
Stimulation of T cell clones. In all, 28 gluten-specific T cell clones were stimulated in 6-well plates coated 
overnight with anti-CD3 (2.5 μg/ml; Biolegend, San Diego, CA, USA) and anti-CD28 (2.5 μg/ml; Biolegend) or 
PBS (negative control) for 0, 10, 30 and 180 min. At each timepoint, cells were harvested for RNA isolation. Cell 
culture medium was harvested after 240 min for proteomic analysis.
RNA isolation and library preparation of stimulated gsTcells. GsTcells were harvested at each time 
point, washed with PBS and resuspended in a lysis buffer (Ambion, Life Technologies, Carlsbad, CA, USA). RNA 
was extracted with the mirVana RNA isolation kit (Ambion) according to the manufacturer’s instructions. The 
quantity and quality of RNA was determined by Bioanalyzer (Agilent technologies, Santa Clara, CA, USA). The 
sequencing libraries were prepared from 1 μg of total RNA using the TruSeq Stranded Total RNA with Ribo-
Zero Globin kit (Illumina, San Diego, CA, USA) according to the manufacturer’s instructions. Sequencing was 
done with the Illumina HiSeq2500 (Illumina).
DNase I hypersensitivity sequencing and analysis. Standard protocols for nuclei isolation, DNase 
I (Roche #04716728001) treatment and library preparation for DNase I hypersensitivity sequencing generated 
within the Blueprint consortium were followed. Protocol  details66 can be found at: http:// www. bluep rint- epige 
nome. eu/ UserF iles/ file/ Proto cols/ Bluep rint_ DNase1_ Proto col. pdf. All samples were sequenced to a sequencing 
depth of approximately 50–60 million 50 bp single-end reads.
Protein analysis. Supernatants from unstimulated and 4 h-stimulated gsTcell cell cultures were taken and 
analyzed with the Immuno-Oncology panel of Olink (http:// www. olink. com/ produ cts/ immuno- oncol ogy). 
Data was analyzed by subtracting relative log2 protein levels in a blank medium control from the relative log2 
protein levels in the supernatants, followed by a two-sided t-test to measure significant change between super-
natants of unstimulated and 4 h-stimulated gsTcells.
Statistical methods. Statistical analyses were performed in R (version 3.6.3)67 unless otherwise specified. 
Visualization of results was done using the R package ggplot2 (version 3.3.0)68.
RNA‑seq quantification. Before alignment, the reverse complement of the fastQ sequences were taken 
using the FASTX-Toolkit69. Alignment was done using Hisat2 (version 2.0.4)70 against the forward strand, with 
default alignment parameters. The reference genome index was made using the Hisat2-build indexer and 1000 
genomes reference genome version GRCh37 v75 with default parameters. For the samples that had paired-end 
data, only the first mate file was used for alignment. Reads mapping to multiple positions were removed. The 
genes were quantified using HTSeq (version 0.6.1.p1)71 with options -m union, -t exon, -stranded yes and other 
options on default.
DE analysis. The raw count matrix, containing 63,682 genes and 112 samples (92 samples from the Leiden 
cohort and 20 from the Oslo cohort), was first filtered to remove any non-expressed genes by selecting only genes 
that had at least 1 read in 20 samples. This resulted in 29,772 genes to be tested for DE effects. Samples from the 
Leiden and Oslo cohorts were then split, and the DE effects assessed separately.
DE effects were quantified using the R package DEseq2 (version 1.26.0)72, including RNAseq batch and sex as 
covariates for the Leiden samples. No covariates were included for the Oslo samples because no sex information 
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was available and all samples had been sequenced in the same batch. DE effects were then mapped between the 
t0 and t10, t10 and t30, and t30 and t180 timepoints. DE effects in the Leiden cohort were filtered on having an 
absolute log2 fold change (log2FC) of at least 1 and an FDR < 0.05. Oslo samples were used as the replication 
cohort, and comparisons between the two were made using unfiltered Oslo data. In total, we identified 3509 
unique DE genes in the Leiden cohort. These genes were used for interpretation and downstream analysis. PC 
analyses were performed on the variance-stabilized count data.
Clustering of DE genes into distinct response patterns. DE genes were clustered into time patterns 
as follows. The gene expression matrix was VST-normalized using DESeq2 (version 1.26.0)72, after which the 
mean expression level for each gene was determined at each of the four time points. Each row was then cen-
tered to mean 0 and scaled to standard deviation of 1. The data was clustered using k-means clustering (k = 6) 
on a Euclidean distance matrix using the R package TCseq (version 1.10.0)73. Cluster number was determined 
by assessing the stability of the clustering in terms of within-cluster sums of squares over 100 iterations of the 
clustering. We then determined that the optimal tradeoff between stability and informativeness of each cluster 
occurred with a cluster number of k = 6. To verify the stability, we ran another 100 random k-means clustering 
runs using different parameters (nstart = 100, k = 6 and iter.max = 1000). This yielded 100 fully stable clusters that 
matched very well with the clustering definition maintained in the manuscript (98.3% of genes matched their 
cluster).
Comparisons with DICE and biopsy‑derived gsTcells data. DE genes from primary naïve CD4+ T 
cells were retrieved from DICE (https:// dice- datab ase. org/) 41. Briefly, naïve CD4+ T cells from healthy donors 
(n = 91) were obtained from blood by FACS and stimulated using aCD3/aCD28 for 4 h. Biopsy-derived gsTcells 
were obtained from Christophersen et al.13 and contained tetramer+ CD4+ T cells and tetramer− CD4+ T cells 
from CeD patients (n = 5) and gut CD4+ T cells from healthy controls (n = 4). First, we obtained all DE genes 
that were significant (adjusted p value < 0.05) and showed an absolute log2FC > 1. Next, we intersected all DE 
genes from each dataset to obtain those that were unique per dataset and those that were shared with gsTcells. 
We then obtained the overlapped DE genes of gsTcells between DICE (n = 1926) and CeD biopsies (n = 144) to 
evaluate the concordance of those genes using the log2FC. The overlapped genes were divided in four quadrants 
(Q1–Q4). Q1 and Q3 included concordant DE genes that were upregulated and downregulated, respectively. 
Q2 and Q4 consisted of non-concordant DE genes, with Q2 being upregulated in gsTcells but not in reference 
dataset and Q4 being vice-versa.
Gene set enrichment analysis. Reactome  pathways74 were used to identify the pathways or biological 
processes that were enriched for each set of genes. This analysis was performed using the R package clusterPro-
filer (version 3.14.3)75. p values were adjusted using the Benjamini–Hochberg procedure to account for multiple 
testing.
Quantification and peak calling of DHS sequencing. DHS reads were aligned to hg19 reference 
genome using bwa (version 0.6.1-r104)76 with default settings, after which duplicates were marked using bamU-
til (version: 1.0.2)77. Alignments were then filtered to have a mapping quality of at least 30 and a primary align-
ment and to not be duplicated using Samtools (version 1.9)78. Peaks were then called using macs2 (version 
2.2.6)79 enabling –broad –nomodel –shift -125 –extsize 250. Peaks were considered at an FDR threshold < 0.05.
Differential peak calling of DHS sequencing. To identify differentially accessible sites between time-
points, consensus peaks were first defined using the R package DiffBind (version 2.14.0)80, after which raw read 
counts were determined for each consensus peak. Differentially accessible peaks were then quantified between t0 
and t10, t10 and t30, and t30 and t180 using DEseq2 (version 1.26.0)72. PC analyses of DHS data were performed 
on the RPKM-normalized log10-transformed read counts for the consensus peaks. Overlap of peaks between 
the gsTcells or public datasets was determined with Bedtools multiinter –cluster. TF binding site enrichment was 
performed with Homer findMotifsGenome.pl with the merged regions of untreated gsTcells as  background81.
Enrichment of differentially expressed genes in celiac disease loci. To test for enrichment of DE 
genes in CeD loci, we used the R package GREA (https:// github. com/ ragui rreg/ GREA, version 0.1.0)19. We 
defined CeD genes as genes within a 125 kb window of a CeD GWAS top SNP. We then generated 10,000 ran-
dom gene-sets that matched the CeD gene-sets in size. The 10,000 random gene-sets were used to generate an 
empirical null distribution of the overlap between our DE gene-set per cluster and the random gene-sets. We 
then estimated the one-sided empirical p value of the enrichment for each cluster of DE genes.
Ethical approval. Biological material was obtained from celiac disease patients according to protocols 
approved by the regional ethics committees (Medical Ethical Committees of VU University Medical Center, 
Leiden University Medical Center and University of Oslo), and the individuals donating material gave their 
written informed consent.
Data availability
All data (RNA-Seq count tables, DHS counts and peaks) required to reproduce this study have been provided 
as supplementary files. The raw RNA-Seq and DNAse reads supporting this study are available upon request to 
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the authors as this is privacy sensitive. All code and scripts used to generate the results and figures are available 
on Github (https:// github. com/ Olivi erBak ker/ gluten_ speci fic_ tcells).
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